$NHI

NATIONAL HEALTH INVESTORS INC (NHI): Completion of Acquisition or Disposition of Assets

NATIONAL HEALTH INVESTORS INC (NHI) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. nhi-20260701 0000877860 FALSE 0000877860 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Reported): July 1

Original reporting
Published Jul 1, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$NHI
Neutral
medium confidence
Mentioned
$NHI
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NHINeutralLow
01

Why it matters

The transaction closed July 1, 2026 for a total purchase price of $560 million; the master lease was terminated for all facilities except four Florida skilled nursing facilities, which were assigned to an NHC subsidiary.

02

Market read

Traders can treat this as confirmation of deal closure and the $560M headline proceeds, but the filing provides no new valuation, guidance, or incremental economics beyond the completion details.

03

What to watch

The filing does not disclose net proceeds, gain/loss, debt paydown, or updated guidance—those items would be more likely to drive repricing than the lease termination/assignment mechanics alone.

Relevance 7/10Novelty 5/10Timing: deal closed and reported after-hours/filing on July 1, 2026

Background

NHI entered a Purchase and Sale Agreement on April 21, 2026 to sell 32 skilled nursing facilities and 3 independent living facilities to a wholly owned subsidiary of National HealthCare Corporation (NHC).

Company-level read

Ticker impact

$NHINeutralMedium confidence
Context

National Health Investors completed the July 1, 2026 sale of 35 leased facilities for $560M and terminated/assigned the master lease accordingly.

Expected impact

Likely limited incremental impact versus what was already disclosed, but could support modest sentiment if investors were waiting for closure confirmation.

Evidence & confidence

This is a primary SEC filing with a concrete closing date and purchase price, but it largely confirms previously reported transaction terms rather than introducing new economics or guidance.

Market effects

Skilled nursing REIT asset sales/lease assignments can shift portfolio composition and future cash yield, but this filing is company-specific.

Florida lease assignment detail may matter for local tenant/lease cash flows, but no broader regional signal is provided.

Limited; this is a domestic REIT transaction with no cross-border implications described.

Counterpoint

Because the transaction was already announced (April 21, 2026), the market may have priced the economics; closure confirmation may not move the stock much.

Key entities

  • National Health Investors, Inc.

    REIT landlord that completed the sale of 35 leased facilities and restructured the master lease for the Florida facilities.

  • NHC/OP, L.P.

    Purchaser entity and wholly owned subsidiary of National HealthCare Corporation that bought the property.

  • National HealthCare Corporation (NHC)

    Stockholder of NHI; its subsidiary assumed the master lease for the four Florida facilities.

Related articles

$RKLBMedAI 8/10

Rocket Lab (RKLB) Won a Major Space Force Contract. Now It Has to Prove Neutron

Rocket Lab (NASDAQ:RKLB) said Aug. 4 it won a $397 million U.S. Space Force contract under the SB-AMTI program to develop, launch and operate Flatellite satellites for airborne target tracking. The work depends on Rocket Lab’s Neutron rocket, whose first flight has been delayed to late 2026 after a Stage 1 tank failure. Rocket Lab reported Q1 FY2026 revenue of $200.3 million.

$DVHighAI 9/10

DoubleVerify Shares Rally After Nielsen Agrees to $2.15 Billion Takeover

DoubleVerify (NYSE:DV) shares rose about 13.6% premarket after Nielsen Holdings agreed to buy DV in an all-cash deal valued at about $2.15 billion. DV shareholders will receive $13.60 per share, a 30% premium to the 60-day VWAP. The boards approved; closing is expected in Q1 2027. Several brokerages cut ratings to Hold/Market Perform with targets at $13.60.

$CHTRMed

Tensions flare as $34-billion Charter-Cox cable deal nears finish line

Charter Communications is nearing California PUC approval for its $34.5B purchase of Cox Enterprises, with a vote scheduled next week. Activists are urging stronger conditions on low-income broadband affordability, disaster response, and diversity and equity commitments. Charter says it will invest at least $275M in network upgrades and $30M in outreach, and the FCC previously approved the deal with DEI safeguards.

MedAI 9/10

Nielsen To Buy DoubleVerify For $2.15 Billion In Ad Measurement Deal

Nielsen agreed to buy DoubleVerify in an all-cash deal valued at about $2.15 billion, paying $13.60 per share, a 30% premium to the stock’s 60-day VWAP as of Aug. 5. The boards approved; closing is expected by Q1 2027, subject to approvals. Pro forma revenue is expected to exceed $4 billion.

$RTXMedAI 8/10

RTX wins up to $745.4 million deal for SM-3 Block IIA interceptors, extending ballistic missile interceptor production through 2031

RTX won a U.S. Department of War deal worth up to $745.4 million for SM-3 Block IIA ballistic missile interceptors, extending production through 2031. The first tranche totals $275.6 million from the U.S. defense budget and $277.6 million from Japan’s MoD. SM-3 Block IIA uses a kinetic warhead and Mk 41 launchers. It saw documented combat use in April 2024 against Iranian missiles.

$UNPMed

BNSF Says UP–NS Merger Remedies Leave Shipper Gaps

BNSF Railway says revised remedies for the proposed Union Pacific–Norfolk Southern merger do not adequately address competition concerns. BNSF claims expanded Committed Gateway Pricing would cover under 1% of U.S. rail traffic and that 60% of eligible shippers would face higher rates. It also argues some protections could expire within three years. The Surface Transportation Board has not ruled.